Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
US Army
Julphar
Merck
Novartis
Dow
Citi
QuintilesIMS
Fuji

Generated: February 23, 2018

DrugPatentWatch Database Preview

EPINASTINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Epinastine Hydrochloride patents expire, and what generic alternatives are available?

Epinastine Hydrochloride is a drug marketed by Akorn, Apotex, Breckenridge Pharm, Sandoz Inc, Somerset Theraps Llc, and Sun Pharm Inds. and is included in six NDAs.

The generic ingredient in EPINASTINE HYDROCHLORIDE is epinastine hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the epinastine hydrochloride profile page.
Summary for EPINASTINE HYDROCHLORIDE
Drug patent expirations by year for EPINASTINE HYDROCHLORIDE

US Patents and Regulatory Information for EPINASTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 204055-001 May 5, 2017 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203384-001 Dec 7, 2016 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 090919-001 Oct 31, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Breckenridge Pharm EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 090870-001 Mar 14, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 091626-001 Oct 31, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Somerset Theraps Llc EPINASTINE HYDROCHLORIDE epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 090951-001 Oct 31, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Teva
Chinese Patent Office
Cerilliant
US Army
Boehringer Ingelheim
Covington
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot